Top 10 Medical Device Technology

Report Overview

Table of Contents

2969.82

Select License Type

£2,969.82	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£3,608.49	Site License Site License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.
£4,566.49	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.
£3,289.15	Hard Copy License Hard Copy License As described. Hard copy reports are dispatched in the post/mail. However, the majority of our reports are in PDF and are either available for immediate download or they are sent by email within hours of purchase.

£2,969.82	Add to Wishlist
Change Currency	GBP EURO USD
	Order By Fax

Market	Healthcare and Medical
Report Type	Market Research
Country	Global
Published	9 September 2009
Number of Pages	210
Report Delivery	Download
Delivery Lead Time	Immediate
Publisher	Markets&Markets
File Format	-

Technological innovations in the medical device industry have led to a radical transformation in patient care. This report identifies the sectors with the industry's most important developments related to patient care, clinical outcomes, and new product development. While the scope of the report is limited to the top ten technologies only, it covers almost the entire medical device market.

Scientific and medical technology breakthroughs - such as minimally invasive surgery (MIS) - have accelerated the accuracy of clinical outcomes and have also reduced recovery times and the medical costs borne by patients. This has led to radical transformation in patient care.

IT integration in medical imaging and medical devices has given a significant boost to the healthcare industry, a trend that is apparent in the market growth of drug eluting stents and telemedicine technologies. The markets covered in the report have a current potential of $454.3 billion and are expected to grow at a CAGR of 9.8% between 2009 and 2014.

Market estimates and forecast
The report provides in-depth market estimates and forecast for top ten medical device technologies as follows:
• Diagnostic imaging (nuclear imaging, interventional radiology, capsule endoscopy and others)
• Drug delivery (needle free injections, transdermal systems, inhalation system, infusion system)
• Molecular diagnostics (biosensors, proteomics, nanotechnology, and others)
• Mobility aid technologies
• Minimal/non-invasive surgery (stents, bariatric surgery, medical robotics and others)
• Micro-fluids and MEMS (Miniature medical pressure sensors, bio chips, protein chips)
• Non-invasive monitoring (continuous blood glucose monitoring)
• Biomaterials (bionic limbs, joint replacement, antimicrobial wound dressing and others)
• Bio-implants (neurostimulation and others)
• Tele-medicines

Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide more than 100 market tables for various geographic regions covering the sub-segments and micro-markets. In addition, the report also provides 50 company profiles for each of its sub-segments.

Speak to an Advisor

Call us on
+44 (0) 203 086 8600

Select License Type

£2,969.82	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£3,608.49	Site License Site License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.
£4,566.49	Corporate License Corporate License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is/are intended for use by an organisation in its entirety. For example, if reports are put on an Intranet or if they are distributed or used by more than one office, division, or country operation, then a Corporate Licence is required.
£3,289.15	Hard Copy License Hard Copy License As described. Hard copy reports are dispatched in the post/mail. However, the majority of our reports are in PDF and are either available for immediate download or they are sent by email within hours of purchase.

£2,969.82	Add to Wishlist
Change Currency	GBP EURO USD

TABLE OF CONTENTS
1. INTRODUCTION
1.1. KEY TAKE AWAYS
1.2. REPORT DESCRIPTION
1.3. MARKETS COVERED
1.4. STAKEHOLDERS
1.4.1.MEDICAL DEVICE MANUFACTURERS
1.4.2.HOSPITAL SURGICAL DEPARTMENTS
1.4.3.CLINICAL RESEARCH FIRMS
1.4.4.BUSINESS RESEARCH AND CONSULTING SERVICE PROVIDERS
2. SUMMARY
3. MARKET OVERVIEW
3.1. COMPARATIVE ANALYSIS OF THE TOP TEN MEDICAL DEVICE TECHNOLOGIES
3.2. EVOLUTION OF MEDICAL DEVICE TECHNOLOGIES
3.3. DEFINING THE TOP TEN MEDICAL DEVICE TECHNOLOGIES MARKET
3.4. PHYSICIANS ADOPTING INNOVATIVE TECHNOLOGIES
3.5. AGING POPULATION DRIVES THE MARKET
3.5.1. OPPORTUNITY LIES IN LESS DEVELOPED COUNTRIES
3.6. SYNERGY BETWEEN TECHNOLOGIES GIVES BETTER OUTCOMES
3.7. PRODUCT RECALLS ARE A MAJOR CHALLENGE
4. DIAGNOSTIC IMAGING
4.1. DRIVERS
4.1.1. EMERGENCE OF NEW TECHNOLOGY
4.1.2. WIDE APPLICATION AREAS
4.1.3. AGING DEMOGRAPHICS
4.1.4. FOCUS ON PREVENTIVE HEALTHCARE
4.1.5. CMS COVERS MORE TESTS
4.2. RESTRAINTS
4.2.1. ECONOMIC SLOWDOWN
4.2.2. REGULATORY BODIES RAISE HEALTHCARE COSTS
4.3. COMPETITIVE LANDSCAPE
4.4. MRI SYSTEMS
4.4.1. DRIVERS
4.4.1.1. Wide Range of Applications
4.4.1.2. Improvement in Telsa Strength
4.4.2. COMPETITIVE LANDSCAPE
4.5. ULTRASOUND SYSTEMS
4.5.1. DRIVERS
4.5.1.1.Untapped Demand in Emerging Markets
4.5.1.2.Booming Refurbished Equipment Market for Ultrasound Systems
4.5.1.3.Increased Use of Ultrasound by EMS
4.5.2. RESTRAINTS
4.5.2.1. Saturation in Core Markets
4.5.2.2. Lack of Clear Reimbursement Policies
4.5.3. COMPETITIVE LANDSCAPE
4.6. X-RAY SYSTEMS
4.6.1. DRIVERS
4.6.1.1. Fine Image Quality
4.6.2. RESTRAINTS
4.6.2.1. Other advanced technologies hindering growth of X-ray market
4.6.2.2. High degree of Competition
4.6.3. COMPETITIVE LANDSCAPE
4.6.3.1. Mergers and Acquisitions
4.6.3.2. New X-ray Systems
4.7. MAMMOGRAPHY EQUIPMENT
4.7.1. DRIVERS
4.7.1.1. Increase in Demand
4.7.1.2. Favorable Reimbursement Scenario
4.8. TOMOGRAPHY EQUIPMENT
4.8.1. DRIVERS
4.8.1.1. Introduction of Higher Slice CT Scanner
4.8.1.2. Increase in Angiogram CT Application
4.8.1.3. Introduction of OCT
4.8.2. RESTRAINTS
4.8.2.1. Shift from a Slice Count Basis to Detector Coverage
4.8.2.2. MRI Moving Ahead of CT Scan
4.8.3. COMPETITIVE DEVELOPMENT
4.9. NUCLEAR IMAGING EQUIPMENT
4.9.1. COMPETITIVE LANDSCAPE
4.9.1.1. Other Developments
4.10. INTERVENTIONAL RADIOLOGY
4.10.1. DRIVERS
4.10.1.1. Advances in Medical Instrumentation and Radiological Imaging Technology
4.10.1.2. Minimally Invasive Imaging Procedures Gaining Popularity
4.10.2. RESTRAINTS
4.10.2.1. Financial Limitation Hinders Capital Investment
4.10.2.2. Lack of Professional Radiologists
4.11. CAPSULE ENDOSCOPY
4.11.1. DRIVERS
4.11.1.1. Increased Application of Capsule Endoscopy
4.11.1.2. FDA Clearances
4.11.2. COMPETITIVE LANDSCAPE
4.12. LASERS - IMAGING
4.12.1. DRIVERS
4.12.1.1. Reasonable Pricing
4.12.1.2. Expansion of scope and opportunities for laser technology
5. DRUG DELIVERY DEVICES
5.1. INHALATION SYSTEMS
5.2. COMPETITIVE LANDSCAPE
5.3. INFUSION SYSTEMS
5.3.1. COMPETITIVE LANDSCAPE
5.4. NEEDLE-FREE INJECTION/TRANSDERMAL SYSTEMS
5.4.1. DRIVERS
5.5. INCREASE IN INCIDENCE OF ARTHRITIS AND HORMONE DEFICIENCY
5.6. OTHER DEVELOPMENTS IN NEEDLE-FREE INJECTION/TRANSDERMAL SYSTEMS MARKET
6. MEDICAL DIAGNOSTICS
6.1. DRIVERS
6.1.1. POPULARITY OF HOME HEALTHCARE 66
6.1.2. DEMAND FOR GENETIC, MOLECULAR DIAGNOSTIC TESTING
6.2. RESTRAINTS
6.2.1. ECONOMIC SLOWDOWN AND INSURANCE ISSUES
6.3. BIOSENSORS
6.3.1. DRIVERS
6.3.1.1. Increase in Biosensor Usage Due To Multiple Applications
6.3.1.2. Unhealthy Lifestyles
6.3.1.3. Miniaturization Key to Success of Biosensors
6.3.2. RESTRAINTS
6.3.2.1. High R&D costs
6.4. IN VITRO DIAGNOSTIC (IVD)
6.4.1. DRIVERS
6.4.1.1. Demand for IVD in Emerging Markets
6.4.1.2. Increasing Need For Diagnostic Services
6.4.1.3. Increasing Accessibility of Healthcare Services
6.4.2. RESTRAINTS
6.4.2.1. Consolidation of Hospital and Commercial Laboratories
6.4.2.2. Intense FDA Scrutiny on IVD Diagnostic Market
6.5. PROTEOMICS FOR MEDICAL DIAGNOSTICS
6.5.1. DRIVERS
6.5.1.1. Proteomics Targeting More Diseases
6.5.1.2. Enables Pharmacological Profiling, Toxicity Testing
6.5.1.3. Detection of Non-communicable Diseases
6.5.2. RESTRAINTS
6.5.2.1. Protein Structuring Needs Expensive Instrumentation
6.5.2.2. Cost and Reimbursement Issues
6.5.2.3. Lack of Technologies to Speed up Validation Process
6.6. NANOTECHNOLOGY FOR MEDICAL DIAGNOSTICS
6.6.1. DRIVERS
6.6.1.1. Increase in Demand for Genetic & Preimplantation Screening
6.6.2. OPPORTUNITY
6.6.2.1. Nanotechnology for Cancer Diagnostics
6.6.3. RESTRAINT
6.6.3.1. Lack of Commercialization
6.6.3.2. Other Developments
6.7. POLYMERASE CHAIN REACTION (PCR)
6.7.1. DRIVERS
6.7.1.1. Potential to Replace Conventional Tests for Diseases
6.7.1.2. FDA Clearance for Real-Time PCR Instrumentation
6.7.2. RESTRAINTS
6.7.2.1. qPCR Technology Replacing Conventional PCR
6.7.2.2. Price sensitivity of PCR technology
6.8. ARRAYS
6.8.1. DRIVERS
6.8.1.1. Demand for Protein Array on Rise
6.8.1.2. Micro Array Technology Classifies Cancers
6.8.1.3. Minimal Use of Materials Makes Microarrays an Inexpensive Technology
7. MOBILITY AID TECHNOLOGIES
7.1. DRIVERS
7.1.1. POPULATION WITH MOBILITY ISSUES 81
7.1.2. SPORTS FOR PHYSICALLY CHALLENGED GAINING POPULARITY
7.1.3. EMERGENCE OF ROBOTICS TECHNOLOGY
7.2. COMPETITIVE LANDSCAPE
7.3. GLOBAL MOBILITY AID TECHNOLOGIES MARKET BY PRODUCTS
7.3.1. WHEELCHAIRS AND RELATED DEVICES
7.3.1.1. Drivers
7.3.1.1.1. Wide Range of Designs, Materials, and Configurations
7.3.1.1.2. Increase in Demand for Power Wheelchair
7.3.1.2. Restraints
7.3.1.2.1. Power Dependence
7.3.1.2.2. Powered Assist Devices are Costly and Less Portable
7.3.1.2.3. Reimbursement Issues with Powered Wheelchairs
7.3.1.3. Competitive Landscape
7.3.2. WALKING-ASSIST DEVICES
7.4. GLOBAL MOBILITY AID DEVICE MARKET BY TECHNOLOGY
7.4.1. ROBOTICS
7.4.2. NON-ROBOTICS
8. MINIMAL INVASIVE/NON-INVASIVE SURGERY
8.1. DRIVERS
8.1.1. LESS PAINFUL AND SHORT CONVALESCENCE
8.1.2. INCREASED NEED OF SURGERIES FOR THE ELDERLY
8.1.3. HIGHER RATE OF ACCEPTANCE
8.2. RESTRAINTS
8.2.1. LIMITED NUMBER OF SURGERIES PERFORMED
8.2.2. SPECIAL TRAINING AND EQUIPMENT REQUIRED
8.3. OPPORTUNITIES
8.3.1. HUGE MARKET SIZE
8.4. STENT
8.4.1. DRIVERS
8.4.1.1. Rise in Cardiovascular Diseases
8.4.1.2. Increasing Incidence of Obesity and Diabetes
8.5. MEDICAL ROBOTICS
8.5.1. DRIVERS
8.5.1.1. Improved Surgical Results
8.5.1.2. Hospitals encourage medical robots
8.5.1.3. Cost effectiveness
8.5.2. COMPETITIVE LANDSCAPE
8.6. LASERS
8.6.1. DRIVERS
8.6.1.1. Growing Awareness
8.6.1.2. Rise in Age-Related Diseases
8.6.2. DEVELOPMENTS
8.7. BARIATRIC SURGERY
8.7.1. DRIVERS
8.7.1.1. Increasing Incidence of Weight Problems
8.7.1.2. Technological Innovation
8.7.1.3. Rising Obesity among Children
9. MICRO- FLUIDS CHIP AND MEMS
9.1. DRIVERS
9.1.1. COST-EFFECTIVE COMPLEX ANALYSIS SYSTEM
9.1.2. ESSENTIAL TOOL FOR MASS SPECTROMETRY
9.1.3. COMPLETE AUTOMATION IN A SINGLE DEVICE
9.1.4. GREATER SPEED & HIGHER QUALITY
9.1.5. MINIMAL REQUIREMENT OF SAMPLES REDUCES COST
9.2. RESTRAINTS
9.2.1. MICROFLUIDIC CHIP TECHNOLOGY CANNOT MIX FLUIDS
9.2.2. LACK OF COMMERCIALIZATION
9.3. MINIATURE MEDICAL PRESSURE SENSORS
9.4. BIOCHIPS
9.4.1. DRIVERS AND RESTRAINTS
9.4.1.1. Application of biochips in personalized medicine
9.4.1.2. Biochips help save time
9.4.1.3. Biochips aid new drug discovery
9.4.1.4. High cost associated with biochips
9.5. COMPETITIVE LANDSCAPE
9.5.1. Other developments
9.5.1.1. DNA CHIPS
9.5.2. LAB CHIPS
9.5.3. PROTEIN CHIPS
9.5.3.1. Developments
10.NON-INVASIVE MONITORING
10.1.BIOSENSORS
10.1.1. WIDE SCALE ACCEPTABILITY OF BIOSENSORS
10.1.2. HIGH COST INVOLVED IN COMMERCIALIZATION
10.1.3. CONTINUOUS GLUCOSE MONITORING
10.1.3.1. Drivers
10.1.3.1.1. Increasing incidence of diabetes
10.1.3.1.2. Convenience of non-invasive continuous glucose monitoring
11.BIOMATERIALS
11.1.INCREASE IN ORTHOPEDIC PROBLEMS
11.2.HIGH DEGREE OF REGULATORY SCRUTINY
11.3.APPLICATIONS OF BIOMATERIALS
11.4.BIONIC LIMBS
11.4.1. COMPETITIVE LANDSCAPE
11.5.BIO-COMPATIBLE MATERIALS
11.5.1. DRIVERS
11.5.1.1. Advancements in nanotechnology
11.5.1.2. Increase in demand of bio-compatible materials
11.5.2. VULCANIZED SILICON-BASED MATERIALS
11.5.3. JOINT REPLACEMENT
11.5.3.1. Drivers
11.5.3.1.1. Increasing acceptability of bone grafts substitutes
11.5.3.2. Restraints
11.5.3.2.1. Rise in prices of titanium
11.5.3.2.2. Modification in reimbursement policies
11.6.ANTIMICROBIAL WOUND DRESSING
11.6.1. DRIVERS
11.6.1.1.1. New products in anti-microbial wound dressing
11.6.1.1.2. Increasing demand in the home healthcare sector
12.BIO-IMPLANTS
12.1.GRAFT-BASED IMPLANTS
12.1.1. DRIVERS
12.1.1.1. Increasing medical acceptance of graft-based implants
12.1.1.2. Increasing popularity of cosmetic surgery
12.1.2. RESTRAINTS
12.1.2.1. Expensive bone grafts
12.2.SYNTHETIC IMPLANTS
12.2.1. DRIVERS
12.2.1.1. Wide range of applications
12.2.1.2. Synthetic implants are bio-compatible
12.2.2. NEUROSTIMULATION
12.2.2.1. Drivers
12.2.2.1.1. Increase in neurological disorders
12.2.2.1.2. Increase in demand for less complicated operating methods
12.2.2.1.3. Short treatment period
12.2.2.1.4. Technological advancements
12.2.2.2.5 The use of implantable neurostimulation devices
12.2.2.2. Opportunities
12.2.2.2.1. Wide range of innovative therapies
12.2.2.2.2. Huge market size encourages market growth
12.2.2.3. Spinal Cord Stimulation (SCS)
12.2.2.3.1. Drivers
12.2.2.3.1.1. Wide range of applications of spinal cord devices
12.2.2.3.1.2. New improved technology in spinal cord stimulator devices
12.2.2.3.2. Opportunities
12.2.2.3.2.1. FDA approval for spinal cord stimulator devices
12.2.2.4. Developments
12.2.2.5. Sacral Nerve Stimulation (SNS)
12.2.2.5.1. Drivers
12.2.2.5.1.1. Rise in number of patients
12.2.2.5.1.2. Sacral stimulation treatments facilitate increased surgical accuracy
12.2.2.5.2. Opportunities
12.2.2.5.2.1. Huge potential in Asian countries
12.2.2.6. Vagus Nerve Stimulation (VNS)
12.2.2.6.1. Drivers
12.2.2.6.1.1. Effective treatment for partial-onset seizures
12.2.2.6.2. Opportunities
12.2.2.6.2.1. Developments for VNS Market
12.2.2.6.2.2. Regulatory Approval for VNS Market
12.2.2.7. Deep Brain Stimulation Systems
12.2.2.7.1. Drivers
12.2.2.7.1.1. Improved treatments results attracting more patients
12.2.2.7.1.2. New and advanced technology provides greater flexibility to neurosurgeons
12.2.2.7.2. Restraints and Opportunities
12.2.2.7.3. Competitive Landscape
13.TELEMEDICINE
13.1.DRIVERS
13.1.1. INCREASE IN INCIDENCE OF CHRONIC DISEASES
13.1.2. COMPLEXITY OF HEALTHCARE NETWORK
13.1.3. INCREASED IT EXPENDITURE
13.1.4. SHIFTING TREND FROM TREATMENT TO EARLY INTERVENTION
13.2.RESTRAINTS
13.2.1. UNCERTAIN REIMBURSEMENT FOR TELEMEDICINE
13.2.2. LACK OF FUNDING FOR TELEMEDICINE PROGRAMS
13.2.3. TELEMEDICINE TECHNOLOGY
13.2.3.1. Hardware
13.2.3.2. Software
13.2.3.3. Network and Telecom
13.2.3.3.1. Telecom and networking market
13.2.3.3.2. Telehome T&N market
13.2.3.3.3. Telehospital/clinics T&N market
14.TOP TEN MEDICAL DEVICE TECHNOLOGIES PATENT ANALYSIS
14.1.GENERAL TRENDS
15.COMPANY PROFILES
15.1.ABBOTT LABORATORIES
15.1.1. OVERVIEW
15.1.2. DEVELOPMENTS
15.2.ATRIUM MEDICAL CORPORATION
15.2.1. OVERVIEW
15.2.2. DEVELOPMENTS
15.3.BOSTON SCIENTIFIC
15.3.1. OVERVIEW
15.3.2. DEVELOPMENTS
15.4.BERCHTOLD CORPORATION (SUBSIDIARY OF BERCHTOLD GMBH & CO. KG)
15.4.1. OVERVIEW & PRODUCTS
15.5.CONOR MEDSYSTEMS, LLC
15.5.1. OVERVIEW
15.5.2. DEVELOPMENTS
15.6.CELONOVA BIOSCIENCES INC
15.6.1. OVERVIEW
15.6.2. DEVELOPMENTS
15.7.ETHICON ENDO-SURGERY
15.7.1. OVERVIEW & DEVELOPMENTS
15.8.INTROMEDIC
15.8.1. OVERVIEW & PRODUCT
15.8.2. DEVELOPMENTS
15.9.HITACHI MEDICAL CORPORATION
15.9.1. OVERVIEW
15.9.2. DEVELOPMENTS
15.10.GIVEN IMAGING
15.10.1. OVERVIEW
15.10.2. DEVELOPMENTS
15.11. GE HEALTHCARE
15.11.1. OVERVIEW
15.11.2. DEVELOPMENTS
15.12.BIOMET, INC
15.12.1. OVERVIEW
15.12.2. DEVELOPMENTS
15.13.SIEMENS MEDICAL SOLUTIONS
15.13.1. OVERVIEW
15.13.2. DEVELOPMENTS
15.14.XTENT, INC.
15.14.1. OVERVIEW & PRODUCTS
15.15.VALLEYLAB
15.15.1. OVERVIEW
15.16.TERUMO MEDICAL CORPORATION
15.16.1. OVERVIEW
15.16.2. DEVELOPMENTS
15.17.MIV THERAPEUTICS, INC.
15.17.1. OVERVIEW
15.17.2. DEVELOPMENTS
15.18.ORBUSNEICH
15.18.1. OVERVIEW & DEVELOPMENTS
15.19.STENTYS S.A.S.
15.19.1. OVERVIEW & DEVELOPMENTS
15.20.MEDINOL LTD.
15.20.1. OVERVIEW
15.20.2. DEVELOPMENTS
15.21.PROSURGICS
15.21.1. OVERVIEW
15.21.2. DEVELOPMENTS
15.22.ROCHE
15.22.1. OVERVIEW
15.22.2. R&D INNOVATIONS
15.23.OLYMPUS
15.23.1. OVERVIEW
15.23.2. DEVELOPMENTS
15.24.MEDTRONIC, INC.
15.24.1. OVERVIEW
15.24.2. DEVELOPMENTS
15.25.SCIENTIFIC INTAKE CO LTD
15.26.SATIETY, INC
15.27.METACURE NV
15.28.LEPTOS BIOMEDICAL, INC.
15.29.SMITH & NEPHEW
15.29.1. OVERVIEW
15.29.2. DEVELOPMENTS
15.30.ENDOART SA
15.31.INTUITIVE SURGICAL, INC
15.31.1. PRODUCTS
15.31.2. DEVELOPMENTS
15.32.ALLERGAN
15.32.1. OVERVIEW
15.33.ENTEROMEDICS
15.33.1. OVERVIEW & PRODUCTS
15.34.HÉLIOSCOPIE SA
15.34.1. OVERVIEW
15.35.KARL-STORZ GMBH & CO. KG
15.35.1. RECENT DEVELOPMENTS
15.36.BARONOVA, INC.
15.36.1. OVERVIEW & PRODUCTS
15.37.ESAOTE SPA
15.37.1. OVERVIEW
15.37.2. DEVELOPMENTS
15.38.STRYKER
15.38.1. OVERVIEW
15.38.2. EVELOPMENTS
APPENDIX

Visitor Comments

All Comments

Change Currency

GBP

EURO

USD

Last Viewed

Top 10 Medical Device Technology

Top 10 Food and Drinks Companies - Emerging opportunities, growth strategies and innovation in the leading players

Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline

Tobacco - Pakistan

Tobacco - Kazakhstan

Healthcare and Medical Company Profiles

Healthcare and Medical Company Profiles contain up to date financial, strategic, operational, SWOT analysis and product information on the activities of thousands of healthcare and medical companies.

Become an Affiliate

Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?

Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website. If a sale is made from your visitor, you earn commission (a fixed percentage of the price of a product).

Custom Research

Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.

Healthcare and Medical	Type	Keywords Phrase All Words Any Word
Microsoft Windows users can hold the CTRL Key to select more than one sector or country at a time. Apple users can hold the CMD Key to do the same.	Country	Industry Sector
Publisher	Order By Relevance Date	Published In

Top 10 Medical Device Technology

Select License Type

Speak to an Advisor

Select License Type

Table of Contents

Visitor Comments

Change Currency

Last Viewed

Healthcare and Medical Company Profiles

Become an Affiliate

Custom Research

News

Market Insights

Companies And Markets

Customer Support

Corporate Accounts

Contact Details

Contrast settings

Text size settings

All
Afghanistan
Africa
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antigua and Barbuda
Argentina
Armenia
Aruba
Asia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia-Herzegovina
Botswana
Bouvet Island
Brazil
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Caribbean
Cayman Islands
Central African Republic
Central America
Central Europe
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Conch Republic
Cook Islands
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Democratic Republic of Congo
Denmark
Djibouti
Dominica
Dominican Republic
Eastern Europe
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Europe
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Global
Greece
Greenland
Grenada
Guadeloupe (French)
Guam (USA)
Guatemala
Guernsey
Guinea
Guinea Bissau
Guyana
Haiti
Heard Island and McDonald Islans
Holy See
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Ivory Coast
Ivory Coast (Cote D`Ivoire)
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kurdistan
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique (French)
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Middle East
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia (French)
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North America
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Island
Poland
Polynesia (French)
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russia
Rwanda
Saint Barthelemy
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Scandinavia
Schengen countries
Senegal
Serbia and Montenegro
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South America
South Georgia and the South Sandwich Islands
South Korea
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste (East Timor)
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Vietnam
Virgin Islands
Wallis and Futuna Islands
Western Sahara
Yemen
Zambia
Zimbabwe

All
Aerospace
Agriculture, Farming & Raw Materials
Automotive and Parts
Business Services
Chemicals
Construction
Consumer Goods
Defence
Energy and Utilities
Environmental
Finance and Banking
Food and Drink
Healthcare and Medical
Industrial
Information Technology
Leisure
Logistics
Media
Paper and Packaging
Publishing and Printing
Real Estate
Retail
Security
Telecommunications
Textiles and Clothing
Transportation
Travel